Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
NCT00978458Phase 3Active, not recruiting
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Nov 2009
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioma, sponsored by Eastern Cooperative Oncology Group. Started Nov 2009; status: active, not recruiting.
02
Drugs
temozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00978458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978458.